Abstract:Abstract Solid cancer cells commonly enter the blood and disseminate systemically, but are highly inefficient at forming distant metastases for poorly understood reasons. We studied the complex and poorly understood process of metastasis by using a clinically relevant model of melanoma metastasis: patient-derived xenografts (PDX) that differ in their capacity to metastasize in NOD-SCID-Il2rg−/− (NSG) mice, mirroring their metastasis histories in the patients from which they were derived. We systematically dissected distinct steps of the metastatic cascade in vivo to show that melanomas had high frequencies of cells that formed subcutaneous tumours, but much lower percentages of cells that formed tumours after intravenous or intrasplenic transplantation, particularly among inefficiently metastasizing melanomas. Using Liquid Chromatography-Mass Spectrometry (LC-MS) and flow cytometry, we discovered that melanoma cells in the blood and visceral organs experienced high levels of oxidative stress not observed in subcutaneous tumours. This work demonstrates that successfully metastasizing melanomas undergo reversible functional and metabolic changes during metastasis that increases their capacity to withstand oxidative stress through an increased dependence on NADPH-generating enzymes in the folate pathway. Chronic antioxidant treatment promotes circulating melanoma cell survival and distant metastases in NSG mice. Folate pathway inhibition, using low-dose methotrexate or depletion of several NADPH-regenerating enzymes, inhibits distant metastases without significantly affecting the growth of subcutaneous tumours in the same mice. We are currently investigating the role of other NADPH-regenerating pathways such as the pentose phosphate pathway in metastasis of human melanoma cells. Finally, we hypothesize that other stress types may also play a role in limiting metastasis in vivo and we are looking for additional metabolic adaptations that may increase stress-resistance of metastasizing melanoma cells and represent novel therapeutic targets in metastatic disease. Citation Format: Elena Piskounova, Michail Agathocleous, Malea Murphy, Zeping Hu, Ralph DeBerardinis, Sean Morrison. Oxidative stress limits metastasis of human melanoma cells. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 2806.

Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS

Correction: Corrigendum: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS

Retraction Note: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Targeted Therapy of Tumors and Cancer Stem Cells based on Oxidant-Regulated Redox Pathway and its Mechanism

Modulating Intracellular Oxidative Stress Via Engineered Nanotherapeutics

Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway

Association of reactive oxygen species levels and radioresistance in cancer stem cells

Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells

Tumor integrin-targeted glucose oxidase enzyme promotes ROS-mediated cell death that combines with interferon alpha therapy for tumor control

Hybrid nano-stimulator for specific amplification of oxidative stress and precise tumour treatment

Table S3 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy

Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells

ROS signalling in the biology of cancer

Erratum: Src activation by β-adrenoreceptors is a key switch for tumour metastasis (Nature Communications (2013) 4 (1403) DOI:10.1038/ncomms2413)

Controlling Cancer Cells Using Reactive Oxygen Species

Mitochondrial Superoxide Anions Induced by Exogenous Oxidative Stress Determine Tumor Cell Fate: an Individual Cell-Based Study

Abstract 2806: Oxidative Stress Limits Metastasis of Human Melanoma Cells

Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer

Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy

Chronic oxidative stress adaptation in head and neck cancer cells generates slow-cyclers with decreased tumour growth in vivo